MabPlex International

United States
Clintonville, Wisconsin, United States, 94538

Company profile

MabPlex International company profile

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. They offer partners contract services from DNA to finished drug product. They offer comprehensive biologics development and manufacturing solutions for customers globally.

Business identity

Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$1M-$10M
Founded
2013-01-01, Year

Headquarters

Postal code
94538
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$129.7M
Last funding
Series B / $70.7M / 2020-06-08
Last equity funding
Series B / $70.7M
Investors
23
Lead investors
4
Articles
6

Founders and investors

Lead investors

DT Capital PartnersHuajin CapitalSDIC Venture CapitalShenzhen Capital Group

Investors

ApollomicsDT Capital PartnersOrbiMedShenzhen Capital GroupThousand Oaks Biopharmaceuticals